Adam F. Sander

1.9k total citations
42 papers, 917 citations indexed

About

Adam F. Sander is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adam F. Sander has authored 42 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adam F. Sander's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Biochemical and Structural Characterization (10 papers) and vaccines and immunoinformatics approaches (8 papers). Adam F. Sander is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Biochemical and Structural Characterization (10 papers) and vaccines and immunoinformatics approaches (8 papers). Adam F. Sander collaborates with scholars based in Denmark, United States and Tanzania. Adam F. Sander's co-authors include Ali Salanti, Morten A. Nielsen, Thor G. Theander, Susan Thrane, Christoph M. Janitzek, Thomas Lavstsen, Mafalda Resende, Willem A. de Jongh, Stine B. Clemmensen and Louise Goksøyr and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.

In The Last Decade

Adam F. Sander

39 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam F. Sander Denmark 17 387 302 291 156 140 42 917
Emily M. Plummer United States 14 256 0.7× 161 0.5× 218 0.7× 59 0.4× 182 1.3× 17 920
Les P. Nagata Canada 20 347 0.9× 240 0.8× 232 0.8× 149 1.0× 77 0.6× 45 930
Christoph M. Janitzek Denmark 9 310 0.8× 167 0.6× 73 0.3× 135 0.9× 108 0.8× 14 540
Philippe Thullier France 25 753 1.9× 306 1.0× 232 0.8× 525 3.4× 185 1.3× 50 1.6k
Peter Schoofs Australia 7 564 1.5× 231 0.8× 130 0.4× 434 2.8× 69 0.5× 9 1.0k
Dace Skrastiņa Latvia 19 301 0.8× 246 0.8× 50 0.2× 95 0.6× 249 1.8× 45 1.0k
Christine M.C. Bank Netherlands 9 274 0.7× 277 0.9× 83 0.3× 80 0.5× 77 0.6× 12 735
Tim D. Jones United Kingdom 14 389 1.0× 162 0.5× 40 0.1× 176 1.1× 126 0.9× 15 783
Ajesh Maewal United States 12 557 1.4× 658 2.2× 102 0.4× 167 1.1× 34 0.2× 13 1.1k
Thomas D. Duensing United States 12 352 0.9× 138 0.5× 89 0.3× 50 0.3× 57 0.4× 17 847

Countries citing papers authored by Adam F. Sander

Since Specialization
Citations

This map shows the geographic impact of Adam F. Sander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam F. Sander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam F. Sander more than expected).

Fields of papers citing papers by Adam F. Sander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam F. Sander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam F. Sander. The network helps show where Adam F. Sander may publish in the future.

Co-authorship network of co-authors of Adam F. Sander

This figure shows the co-authorship network connecting the top 25 collaborators of Adam F. Sander. A scholar is included among the top collaborators of Adam F. Sander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam F. Sander. Adam F. Sander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palladini, Arianna, Patrizia Nanni, Louise Goksøyr, et al.. (2025). Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma. Journal of Translational Medicine. 23(1). 136–136. 3 indexed citations
2.
Herrero-Fresno, Ana, Mauro de Mesquita Souza Saraiva, Nicole Bakkegård Goecke, et al.. (2025). Outer Membrane Proteins as Vaccine Targets Against Lawsonia intracellularis in Piglets. Vaccines. 13(2). 207–207.
3.
4.
Kang, Hyeog, et al.. (2024). Capsid virus-like particle display improves recombinant influenza neuraminidase antigen stability and immunogenicity in mice. iScience. 27(6). 110038–110038. 4 indexed citations
5.
Myeni, Sebenzile K., Peter J. Bredenbeek, Cyrielle Fougeroux, et al.. (2024). Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine. Vaccines. 12(7). 766–766. 1 indexed citations
6.
7.
Fougeroux, Cyrielle, et al.. (2024). Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1. PLoS ONE. 19(7). e0302243–e0302243. 1 indexed citations
8.
Zielke, Ryszard A., et al.. (2023). Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme. Infection and Immunity. 91(12). e0024523–e0024523. 6 indexed citations
9.
Guerra, Priscila R., Ana Herrero-Fresno, Mauro de Mesquita Souza Saraiva, et al.. (2023). A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows. Pathogens. 12(12). 1388–1388. 3 indexed citations
10.
Skov, Jakob, et al.. (2023). High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout. Frontiers in Immunology. 14. 1139206–1139206. 1 indexed citations
11.
Prentoe, Jannick, Christoph M. Janitzek, Rodrigo Velázquez‐Moctezuma, et al.. (2022). Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers. npj Vaccines. 7(1). 148–148. 6 indexed citations
12.
Goksøyr, Louise, Maureen Sampson, Morten A. Nielsen, et al.. (2022). A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines. 11(1). 2–2. 10 indexed citations
13.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2022). Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein. Nanotechnology. 33(48). 485102–485102. 6 indexed citations
14.
Prentoe, Jannick, Christoph M. Janitzek, Rodrigo Velázquez‐Moctezuma, et al.. (2021). Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens. PLoS ONE. 16(7). e0255336–e0255336. 2 indexed citations
15.
16.
Janitzek, Christoph M., Julianne Peabody, Susan Thrane, et al.. (2019). A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine. Scientific Reports. 9(1). 5260–5260. 46 indexed citations
17.
Matondo, Sungwa, Susan Thrane, Christoph M. Janitzek, et al.. (2017). A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses. African Health Sciences. 17(2). 373–373. 5 indexed citations
18.
Thrane, Susan, Christoph M. Janitzek, Mette Ø. Agerbæk, et al.. (2015). A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA. PLoS ONE. 10(11). e0143071–e0143071. 48 indexed citations
19.
Sander, Adam F., Ali Salanti, Thomas Lavstsen, et al.. (2011). Positive Selection of Plasmodium falciparum Parasites With Multiple var2csa-Type PfEMP1 Genes During the Course of Infection in Pregnant Women. The Journal of Infectious Diseases. 203(11). 1679–1685. 21 indexed citations
20.
Sander, Adam F., Ali Salanti, Thomas Lavstsen, et al.. (2009). Multiple var2csa-Type PfEMP1 Genes Located at Different Chromosomal Loci Occur in Many Plasmodium falciparum Isolates. PLoS ONE. 4(8). e6667–e6667. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily M. Plummer Breakdown of academic impact, for papers by Les P. Nagata Breakdown of academic impact, for papers by Christoph M. Janitzek Breakdown of academic impact, for papers by Philippe Thullier Breakdown of academic impact, for papers by Peter Schoofs Breakdown of academic impact, for papers by Dace Skrastiņa Breakdown of academic impact, for papers by Christine M.C. Bank Breakdown of academic impact, for papers by Tim D. Jones Breakdown of academic impact, for papers by Ajesh Maewal Breakdown of academic impact, for papers by Thomas D. Duensing
Rankless by CCL
2026